Three U.S. Senators introduced new legislation last week in an effort to bolster treatment innovation by pharmaceutical companies for rare and neglected pediatric diseases. Sens. Sherrod Brown (D-OH), Sam Brownback (R-KS) and Al Franken (D-MN) proposed The Creating Hope Act of 2010 (S. 3697) in a bipartisan effort that builds on the FDA Amendments Act […]
HIV
The following is a guest post by Maureen Luba Milambe, African Regional Advocacy Advisor, AVAC On Tuesday (June 8), the UN General Assembly voted overwhelmingly to […]
Tuberculosis
The publication of trial data showing a four-month treatment regimen for tuberculosis that is not resistant to first-line medicines as effective as the currently widely prescribed […]
Research & Development
By Mitchell Warren, executive director, AVAC In February 2020, just as the COVID pandemic began its rapid global spread, a major HIV vaccine trial called HVTN […]
Policy
By Karen Carvajal, M.D. Over the course of human history we have come a long way in our fight against the threat of infectious diseases and, […]